What Is Multiple Myeloma Understanding the Basics of This Blood Cancer

Multiple myeloma is a blood cancer that starts in a type of white blood cell called a plasma cell. When those cells grow out of control, they can crowd out healthy blood-making cells and release abnormal proteins that strain your kidneys and weaken your bones. If you are here because of back pain that will not quit, unexplained anemia, high calcium, or a lab report mentioning an “M protein,” you are not overreacting. Myeloma can be subtle at first, and it is often found after months of vague symptoms or an “off” blood test. In this guide, you will learn what multiple myeloma is, what it tends to feel like in real life, how doctors confirm it, and what treatment usually looks like. If you are trying to make sense of labs or decide what to ask next, Vitals Vault labs and PocketMD can help you organize questions and next steps, but the goal here is clarity first.

Symptoms and signs you might notice

• Bone pain that feels deep

  Myeloma can weaken the inside of your bones, especially in your spine, ribs, hips, and skull. That often shows up as a deep ache that is worse with movement or at night, not just a sore muscle after activity. If you suddenly get severe back pain, new numbness, or trouble controlling your bladder, treat it as urgent because a spine fracture or pressure on the spinal cord needs fast care.

• Fatigue from low red blood cells

  When cancerous plasma cells crowd your bone marrow, your body may make fewer red blood cells, which causes anemia. You can feel wiped out, short of breath on stairs, or like your heart is working harder than it should. This kind of fatigue does not improve much with sleep because the problem is oxygen delivery, not motivation.

• Frequent infections that linger

  Plasma cells normally help you fight germs, but in myeloma they make a lot of one ineffective antibody while your useful antibodies drop. That can look like sinus infections that keep coming back, pneumonia, or infections that take longer to clear even with antibiotics. If you are getting repeated infections, it is a clue that your immune system may be off balance.

• Kidney trouble or foamy urine

  The abnormal protein made by myeloma cells can clog and inflame your kidneys, which may show up as rising creatinine on labs before you feel anything. Some people notice swelling in their legs, less urine, or urine that looks unusually foamy. Kidney strain matters because it can limit medication choices and it is often reversible when treated early.

• Thirst, constipation, or confusion

  Bone breakdown can release extra calcium into your blood, which is why myeloma is linked with “high calcium.” High calcium can make you very thirsty, constipated, nauseated, or mentally foggy, and it can worsen dehydration and kidney injury. If you feel confused, very weak, or cannot keep fluids down, you should be seen the same day.

What causes multiple myeloma and who is at risk

• A plasma cell grows out of control

  Multiple myeloma starts when one plasma cell in your bone marrow picks up genetic changes that let it keep dividing. Over time, that clone pushes out normal marrow cells and produces an abnormal antibody protein. The “so what” is that one cell line can create problems in several organs at once, which is why symptoms can seem unrelated.

• Age and immune system wear-and-tear

  Myeloma is much more common as you get older, partly because DNA damage accumulates over decades. That does not mean you did something wrong; it is a biology-and-time problem. It also explains why doctors take persistent anemia, bone pain, or kidney changes more seriously in older adults.

• Family history and inherited risk

  Having a close relative with myeloma or related plasma cell disorders slightly raises your risk. Most people with myeloma still have no clear family pattern, but family history can lower the threshold for testing if symptoms show up. If you know myeloma runs in your family, tell your clinician early rather than waiting for symptoms to stack up.

• A precursor condition found on labs

  Some people have an early, silent stage where a small amount of abnormal protein is present without organ damage. This is often called a “precancer” stage (MGUS) on first mention, and it can progress slowly, stay stable for life, or move toward myeloma. If you have been told you have MGUS or “smoldering” myeloma, your main job is consistent monitoring so changes are caught before organs are affected.

• Certain exposures and health inequities

  Research links myeloma risk with some chemical exposures and with higher rates in certain populations, including Black Americans. The reasons are likely a mix of biology, environment, and differences in access to early diagnosis and specialty care. For you, the practical takeaway is to take persistent symptoms seriously and ask directly whether myeloma has been considered.

How doctors diagnose multiple myeloma

• Blood tests for abnormal proteins

  A key step is looking for the abnormal antibody made by myeloma cells, often called an “M protein” on reports. Doctors typically use serum protein electrophoresis and immunofixation, plus a serum free light chain test, to measure and characterize it. These tests help separate myeloma from other causes of inflammation or anemia and give a baseline to track treatment response.

• Checks on anemia, kidneys, and calcium

  A complete blood count can show anemia, while a metabolic panel can show kidney strain and high calcium. These results matter because they are not just “numbers”; they reflect whether myeloma is already affecting organs. They also guide how urgently you need treatment and which supportive therapies you may need right away.

• Urine testing for light chains

  Some myeloma proteins spill into urine, and they can be especially hard on the kidneys. A 24-hour urine collection or specialized urine protein testing can detect and quantify these proteins. If your urine tests are positive, it often changes how closely your kidneys are monitored during treatment.

• Imaging and bone marrow confirmation

  Imaging looks for bone damage and hidden fractures, and modern scans can find lesions before they show up on plain X-rays. To confirm the diagnosis, doctors usually do a bone marrow biopsy, which counts plasma cells and checks genetic features that influence risk and treatment planning. It is normal to dread this test, but it provides the information that turns uncertainty into a plan.

Treatment options you may hear about

• Targeted drug combinations

  Many people start with a combination of medicines that attack myeloma cells in different ways, often including a proteasome inhibitor, an immune-modulating drug, and a steroid. The point of combination therapy is to shrink the cancer quickly and reduce organ stress, especially on bones and kidneys. Your team adjusts the mix based on your age, other conditions, and how aggressive the myeloma appears.

• Monoclonal antibodies and immunotherapy

  Some treatments use lab-made antibodies that recognize markers on myeloma cells and help your immune system clear them. These drugs can deepen responses and are often added when myeloma is newly diagnosed or if it returns. You may hear about newer immune approaches like CAR-T cells or bispecific antibodies, which can be options in certain situations and are changing what “later lines” of therapy look like.

• Stem cell transplant for eligible people

  A stem cell transplant in myeloma usually means using your own stem cells (autologous transplant) after high-dose chemotherapy. It is not the right fit for everyone, but for many it can extend remission and improve long-term control. Even if you are not ready to decide, early referral to discuss eligibility can keep options open.

• Bone-strengthening and fracture care

  Because myeloma weakens bone, treatment often includes drugs that slow bone breakdown, along with vitamin D assessment and careful calcium guidance. If you have a painful lesion or fracture risk, radiation or procedures like vertebroplasty can reduce pain and stabilize the spine. This is about function as much as cancer control, because being able to move and sleep changes everything.

• Supportive care for kidneys and blood counts

  Your care plan may include fluids, medication adjustments, and avoiding certain pain relievers that can worsen kidney function. If anemia is severe, you might need transfusions or other strategies while the main treatment starts working. Supportive care is not “extra”; it is how you stay strong enough to tolerate therapy and recover between cycles.

Living with multiple myeloma day to day

• Make symptoms measurable, not mysterious

  Keeping a simple weekly record of pain level, energy, infections, and side effects helps you and your team spot patterns early. It also makes appointments more productive because you are not relying on memory during a stressful conversation. If something changes quickly, that record helps you explain what “quickly” actually means.

• Protect your bones in real life

  With myeloma, “be careful” is too vague, so focus on specific habits that reduce falls and sudden spine strain. Ask about safe strength training, footwear, and whether you should avoid heavy lifting or twisting movements. If you have new focal bone pain, do not push through it like a workout injury, because imaging may be needed.

• Lower infection risk without isolating

  Treatment can weaken your immune defenses, so prevention becomes practical: staying current on vaccines your team recommends, washing hands, and avoiding close contact with sick people when your counts are low. You do not have to live in a bubble, but you do need a plan for what you will do if you develop fever or a new cough. Many clinics give you a clear “call us first” pathway, and it is worth saving that number.

• Mental load and caregiver teamwork

  Myeloma often comes with cycles of waiting, testing, and adjusting, which can make you feel like you can never fully relax. It helps to bring one person to key visits, even by speakerphone, so you are not carrying every detail alone. If anxiety or low mood is sticking around most days, tell your team, because support and treatment can improve your quality of life as much as any medication.

Prevention and risk reduction: what’s realistic

• You cannot fully prevent myeloma

  There is no proven way to guarantee you will not develop multiple myeloma, and that can be frustrating. The disease usually comes from internal genetic changes over time rather than a single controllable trigger. What you can control is how early it is recognized and how well complications are prevented.

• If you have MGUS, monitor on schedule

  If you have the precursor condition MGUS, the most effective “prevention” is consistent follow-up so progression is caught before organs are damaged. Monitoring usually involves periodic blood and sometimes urine tests, and the interval depends on your risk features. Skipping checks can turn a manageable change into an emergency later.

• Protect kidneys and bones proactively

  If you are at risk or being monitored, staying well-hydrated and discussing kidney-safe pain control can matter more than people realize. For bones, ask whether you need vitamin D testing, fall-risk assessment, or physical therapy guidance. These steps do not prevent myeloma itself, but they can reduce the harm it causes while you are being evaluated.

• Know when to seek urgent evaluation

  Some symptoms should not wait for a routine appointment, especially fever during treatment, sudden severe back pain, new weakness or numbness, confusion, or signs of dehydration. These can signal infection, spinal cord pressure, or high calcium, all of which are time-sensitive. Acting quickly can prevent long-term damage and shorten recovery.

Related topics you might also want to read

Frequently Asked Questions